SCCM Resource Library-Ketamine, Gabapentin, and Dexmedetomidine: Fancy Like a Tiny Umbrella or Muddled Herbs

Ketamine, Gabapentin, and Dexmedetomidine: Fancy Like a Tiny Umbrella or Muddled Herbs

Video Transcription

Video Summary

Dipali Dixit, a clinical associate professor at Rutgers University, discussed the role of ketamine, dexmedetomidine, and gabapentin as adjunctive therapies for severe alcohol withdrawal management. Ketamine, an NMDA receptor antagonist, may help reduce benzodiazepine requirements despite mixed study results. Dexmedetomidine improves short-term alcohol withdrawal symptoms but cannot be used alone due to the lack of GABA activity. Gabapentin helps manage symptoms, though evidence primarily comes from non-ICU settings. Dixit emphasized the need for further research to establish optimal dosing and identify patients who would benefit most.

Asset Caption

45-Minute Session | 12 (or So) Steps for Putting "Happy" Back in "Happy Hour": Strategies for Alcohol Withdrawal

Meta Tag

Content Type Presentation

Membership Level Professional

Membership Level Select

Year 2024

Keywords

ketamine

dexmedetomidine

gabapentin

alcohol withdrawal

adjunctive therapies

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.